Sherry J. Morgan

790 total citations
17 papers, 488 citations indexed

About

Sherry J. Morgan is a scholar working on Molecular Biology, Small Animals and Equine. According to data from OpenAlex, Sherry J. Morgan has authored 17 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Small Animals and 4 papers in Equine. Recurrent topics in Sherry J. Morgan's work include Animal testing and alternatives (4 papers), Veterinary Equine Medical Research (4 papers) and Immunotoxicology and immune responses (3 papers). Sherry J. Morgan is often cited by papers focused on Animal testing and alternatives (4 papers), Veterinary Equine Medical Research (4 papers) and Immunotoxicology and immune responses (3 papers). Sherry J. Morgan collaborates with scholars based in United States, United Kingdom and Egypt. Sherry J. Morgan's co-authors include David M. Hood, Deborah A. Grosenbaugh, Shawn Berens, Allison Vitsky, Chandikumar S. Elangbam, Evan B. Janovitz, Tanja S. Zabka, Ilka Wagner, J. Ruth Wu-Wong and Masaki Nakane and has published in prestigious journals such as Blood, Analytical Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Sherry J. Morgan

17 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherry J. Morgan United States 11 169 131 62 61 52 17 488
Kumiko Oida Japan 14 9 0.1× 136 1.0× 5 0.1× 5 0.1× 104 2.0× 32 590
R. S. Hotchkiss United States 5 4 0.0× 228 1.7× 10 0.2× 39 0.6× 277 5.3× 9 588
Judith Hunter United Kingdom 11 16 0.1× 92 0.7× 15 0.2× 2 0.0× 20 0.4× 17 344
Enzo Poli Italy 12 22 0.1× 136 1.0× 7 0.1× 1 0.0× 99 1.9× 37 358
Emily C. Graff United States 12 4 0.0× 228 1.7× 9 0.1× 7 0.1× 39 0.8× 33 609
L. J. F. Youlten United Kingdom 16 6 0.0× 65 0.5× 5 0.1× 8 0.1× 108 2.1× 41 1.1k
Yohnosuke Kobayashi Japan 10 3 0.0× 115 0.9× 5 0.1× 61 1.0× 49 0.9× 20 422
Gustavo Negri Argentina 11 3 0.0× 89 0.7× 4 0.1× 6 0.1× 34 0.7× 33 398
Luan Li China 13 1 0.0× 88 0.7× 5 0.1× 30 0.5× 98 1.9× 46 448
Jinqi Xia United States 8 7 0.0× 64 0.5× 3 0.0× 74 1.4× 14 391

Countries citing papers authored by Sherry J. Morgan

Since Specialization
Citations

This map shows the geographic impact of Sherry J. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry J. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry J. Morgan more than expected).

Fields of papers citing papers by Sherry J. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry J. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry J. Morgan. The network helps show where Sherry J. Morgan may publish in the future.

Co-authorship network of co-authors of Sherry J. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry J. Morgan. A scholar is included among the top collaborators of Sherry J. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry J. Morgan. Sherry J. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sura, Radhakrishna, Julie A. Hutt, & Sherry J. Morgan. (2021). Opinion on the Use of Animal Models in Nonclinical Safety Assessment: Pros and Cons. Toxicologic Pathology. 49(5). 990–995. 6 indexed citations
2.
Blanset, Diann, Julie A. Hutt, & Sherry J. Morgan. (2020). Current use of animal models of disease for nonclinical safety testing. Current Opinion in Toxicology. 23-24. 11–16. 5 indexed citations
3.
Morgan, Sherry J., Jessica A. Couch, Peggy Guzzie‐Peck, et al.. (2017). Regulatory Forum Opinion Piece*: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry Survey. Toxicologic Pathology. 45(3). 372–380. 9 indexed citations
4.
Morgan, Sherry J., et al.. (2016). Copovidone-related Cutaneous Response in the Dog. Toxicologic Pathology. 45(1). 84–89. 1 indexed citations
5.
Gagné, Gerard D., Sherry J. Morgan, Bruce E. LeRoy, et al.. (2012). Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure models. Journal of Pathology Informatics. 3(1). 20–20. 28 indexed citations
6.
Morgan, Sherry J., Chandikumar S. Elangbam, Shawn Berens, et al.. (2012). Use of Animal Models of Human Disease for Nonclinical Safety Assessment of Novel Pharmaceuticals. Toxicologic Pathology. 41(3). 508–518. 59 indexed citations
7.
Luo, Yanping, Vincent P. Hradil, David J. Frost, et al.. (2009). ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature. Anti-Cancer Drugs. 20(6). 483–492. 32 indexed citations
8.
Wilcox, Denise M., Ruojing Yang, Sherry J. Morgan, et al.. (2006). Delivery of RNAi reagents in murine models of obesity and diabetes.. Europe PMC (PubMed Central). 8 indexed citations
9.
Elmore, Steven W., Joy Bauch, Ryan M. Fryer, et al.. (2006). Bcl-2 Family Protein Inhibitors Induce a Unique Thrombocytopenia In Vivo.. Blood. 108(11). 4236–4236. 2 indexed citations
10.
Wu-Wong, J. Ruth, William T. Noonan, Junli Ma, et al.. (2006). Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification. Journal of Pharmacology and Experimental Therapeutics. 318(1). 90–98. 69 indexed citations
11.
12.
Morgan, Sherry J., et al.. (2003). Submural histopathologic changes attributable to peracute laminitis in horses. American Journal of Veterinary Research. 64(7). 829–834. 29 indexed citations
13.
Waring, Jeffrey F., Rita Ciurlionis, Jill E. Clampit, et al.. (2003). PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat. Molecular and Cellular Endocrinology. 203(1-2). 155–168. 33 indexed citations
14.
Grosenbaugh, Deborah A., Sherry J. Morgan, & David M. Hood. (1999). The Digital Pathologies of Chronic Laminitis. Veterinary Clinics of North America Equine Practice. 15(2). 419–436. 13 indexed citations
15.
Morgan, Sherry J., Deborah A. Grosenbaugh, & David M. Hood. (1999). The Pathophysiology of Chronic Laminitis. Veterinary Clinics of North America Equine Practice. 15(2). 395–417. 36 indexed citations
16.
O'Neill, Alyssa B., Sherry J. Morgan, & Jorge D. Brioni. (1998). Histological and Behavioral Protection by (−)-Nicotine against Quinolinic Acid-Induced Neurodegeneration in the Hippocampus. Neurobiology of Learning and Memory. 69(1). 46–64. 18 indexed citations
17.
Hood, David M., et al.. (1993). The Role of Vascular Mechanisms in the Development of Acute Equine Laminitis. Journal of Veterinary Internal Medicine. 7(4). 228–234. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026